Portopulmonary Hypertension - 09/08/11
Doi : 10.1016/j.ccm.2006.11.004
Jason M. Golbin, DO, MS a, Michael J. Krowka, MD a, b, ⁎ 
a Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
b Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Corresponding author. Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905.Abstract |
As a result of the success of orthotopic liver transplantation, there has been increasing interest in the diagnosis and therapeutic options for the pulmonary vascular complications of hepatic disease. These pulmonary vascular complications range from the hepatopulmonary syndrome, which is characterized by intrapulmonary vascular dilatations, to portopulmonary hypertension (POPH), which is characterized by an elevated pulmonary vascular resistance as a consequence of obstruction to pulmonary arterial blood flow. This review concentrates on POPH.
Le texte complet de cet article est disponible en PDF.Plan
© 2007
Elsevier Inc. Tous droits réservés.
Vol 28 - N° 1
P. 203-218 - mars 2007 Retour au numéro
Article précédent
- Surgical Therapies for Pulmonary Arterial Hypertension
- Jeffrey S. Sager, Vivek N. Ahya
- Pulmonary Hypertension Associated with Chronic Respiratory Disease
- Reda E. Girgis, Stephen C. Mathai
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?